1. Modulation of CD4 T cell function via CD6-targeting
- Author
-
S. Almeida, Afonso P. Basto, Vanessa G. Oliveira, Kalet León, Rita F. Santos, Luis Graca, Carine M. Gonçalves, Jesus Corria-Osorio, Raquel F. Freitas, Alexandre M. Carmo, Tânia Carvalho, and Instituto de Investigação e Inovação em Saúde
- Subjects
Antigens, Differentiation, T-Lymphocyte ,CD4-Positive T-Lymphocytes ,Fetal Proteins ,CD4-Positive T-Lymphocytes / metabolism ,0301 basic medicine ,Research paper ,Lymphocyte Activation ,Immunological synapse ,Mice ,0302 clinical medicine ,T-Lymphocyte Subsets ,Cell Adhesion Molecules, Neuronal / metabolism ,Antigens, Differentiation, T-Lymphocyte / metabolism ,Cd4 t cell ,EAE ,FOXP3 ,Cell Differentiation ,General Medicine ,T-cell polarization ,Cell biology ,medicine.anatomical_structure ,Foxp3 ,030220 oncology & carcinogenesis ,Antibody ,Cell Adhesion Molecules, Neuronal ,T cell ,CD4 T cells ,Mice, Transgenic ,Biology ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,Antigens, CD ,In vivo ,CD4-Positive T-Lymphocytes / immunology ,medicine ,Animals ,Humans ,T-Lymphocyte Subsets / metabolism ,Antigens, CD / metabolism ,CD4-Positive T-Lymphocytes / cytology ,CD6 ,Fetal Proteins / metabolism ,In vitro ,030104 developmental biology ,biology.protein ,Treg cells ,Biomarkers ,Function (biology) ,T-Lymphocyte Subsets / immunology - Abstract
In recent years molecules involved on the immune synapse became successful targets for therapeutic immune modulation. CD6 has been extensively studied, yet, results regarding CD6 biology have been controversial, in spite of the ubiquitous presence of this molecule on virtually all CD4 T cells. We investigated the outcome of murine and human antibodies targeting CD6 domain 1. We found that CD6-targeting had a major impact on the functional specialization of CD4 cells, both human and murine. Differentiation of CD4 T cells towards a Foxp3+ Treg fate was prevented with increasing doses of anti-CD6, while Th1 polarization was favoured. No impact was observed on Th2 or Th17 specialization. These in vitro results provided an explanation for the dose-dependent outcome of in vivo anti-CD6 administration where the anti-inflammatory action is lost at the highest doses. Our data show that therapeutic targeting of the immune synapse may lead to paradoxical dose-dependent effects due to modification of T cell fate. Funded by UID/BIM/50005/2019, project funded by Fundação para a Ciência e a Tecnologia (FCT) / Ministério da Ciência, Tecnologia e Ensino Superior (MCTES) throught Fundos do Orçamento do Estado, pela Fundação para a Ciência e a Tecnologia (FCT) ( PTDC/DTP-FTO/3080/2014 ); and by the project SRecognite Infect - ERA/0003/2015 using national funds through FCT . Funders did not have a role in study design, data collection, analysis, and interpretation, or in the writing of the manuscript.
- Published
- 2019